STOCK TITAN

Chemed Corporation - $CHE STOCK NEWS

Welcome to our dedicated page for Chemed Corporation news (Ticker: $CHE), a resource for investors and traders seeking the latest updates and insights on Chemed Corporation stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Chemed Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Chemed Corporation's position in the market.

Rhea-AI Summary

Chemed (CHE) will present at the Bank of America Securities Health Care Conference 2024 on May 14, 2024. The presentation will be webcast live and available for replay on the Chemed website. Chemed operates VITAS Healthcare and Roto-Rooter, with a focus on end-of-life hospice care and plumbing services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.63%
Tags
conferences
-
Rhea-AI Summary
Chemed (NYSE: CHE) reported positive financial results for the first quarter of 2024, with a 5.2% revenue increase to $589.2 million. GAAP Diluted EPS increased by 18.4% to $4.24, while Adjusted Diluted EPS rose by 21.5% to $5.20. VITAS segment saw growth in Net Patient Revenue, ADC, and Admissions. Roto-Rooter segment experienced a decrease in revenue but maintained a 51.9% gross margin. Chemed had total cash of $313.4 million with no debt. Management provided a full-year 2024 earnings per diluted share guidance range of $23.30 to $23.70.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.22%
Tags
-
Rhea-AI Summary
VITAS Healthcare , a subsidiary of Chemed , completed the purchase of hospice operations and an assisted living facility from Covenant Health and Community Services for $85 million. The transaction covers Florida and Alabama markets and closed on April 17, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.95%
Tags
none
Rhea-AI Summary
Chemed (CHE) to Release Q1 2024 Financial Results; Conference Call Scheduled for April 25, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.2%
Tags
conferences earnings
-
Rhea-AI Summary
VITAS Healthcare Corporation, a subsidiary of Chemed Corporation, acquires hospice operations and assisted living facility from Covenant Health and Community Services for $85 million. The transaction spans Florida and Alabama markets and is set to close in the second quarter.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
none
-
Rhea-AI Summary
Chemed Corporation (NYSE:CHE) will present at the Oppenheimer 34th Annual Healthcare Conference. The virtual presentation will be webcast live on March 12, 2024, accessible on the Chemed website. Chemed operates VITAS Healthcare and Roto-Rooter, focusing on end-of-life hospice care and plumbing services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.5%
Tags
conferences
Rhea-AI Summary
Chemed Corporation (CHE) reported financial results for Q4 2023, showing revenue growth of 7.2%. VITAS segment saw a 13.6% increase in net patient revenue, while Roto-Rooter experienced a 1.1% revenue decline. Chemed had total cash of $264.0 million with no debt as of December 31, 2023. 2024 guidance predicts VITAS revenue to increase by 9.0% to 9.8% and Roto-Rooter revenue to grow by 3.5% to 4.0%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.4%
Tags
-
Rhea-AI Summary
Chemed Corporation (CHE) declares a quarterly cash dividend of 40 cents per share, maintaining its 211th consecutive quarterly dividend payment. The dividend will be paid on March 15, 2024, to shareholders of record as of February 26, 2024. Chemed, a public company for 52 years, operates VITAS Healthcare and Roto-Rooter.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.2%
Tags
dividends
-
Rhea-AI Summary
Chemed Corporation (CHE) announced the release of financial results for Q4 2023 on February 27, 2024. A conference call is scheduled for February 28, 2024, to discuss quarterly results and business updates. Chemed operates VITAS Healthcare and Roto-Rooter, with a focus on end-of-life hospice care and plumbing services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.32%
Tags
conferences earnings
Rhea-AI Summary
Chemed Corporation (NYSE:CHE) to Present at 42nd Annual JPMorgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
conferences
Chemed Corporation

NYSE:CHE

CHE Rankings

CHE Stock Data

8.75B
14.83M
2.39%
97.7%
2.98%
Home Health Care Services
Health Care and Social Assistance
Link
United States of America
CINCINNATI

About CHE

chemed is a holding company. our wholly owned subsidiaries are vitas and roto-rooter services company. vitas is a healthcare company that specializes in hospice or end of life care for the terminally ill. roto-rooter is the nation's largest provider of plumbing and drain care services.